Oxford BioMedica to present at Biotech Showcase

8 January 2014

Oxford, UK – 9 January 2014: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE: OXB), the leading gene-based biopharmaceutical company, announces that John Dawson, Chief Executive Officer, will present a company overview at the Biotech Showcase 2014 Conference in San Francisco, California, on Tuesday, 14 January, 2014 at 3:00 p.m. Pacific Time.